+ All Categories
Home > Documents > Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the...

Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the...

Date post: 04-Jul-2020
Category:
Upload: others
View: 2 times
Download: 0 times
Share this document with a friend
15
6/24/17 1 Tom Depuydt, ir, PhD Head of Medical Physics Radiation Oncology department UZ Leuven and ParTICLe Proton Therapy Center KU Leuven Proton Therapy Technology in the Clinic Scientific Meeting BVS-ABR: “Proton therapy – From the Need to the Solution” June 23 rd 2017 From radiation physics to a clinical radiotherapy treatment modality depth dose Protons loose kinetic energy gradually w hen travelling through matter, through multiple collisions with atomic electrons The rate of energy loss or “ stopping power depends on the kinetic energy its elf Multiple Coulomb interactions with atomic nuclei make protons scatter Non-elastic collisions with atomic nuclei knocks out one or more protons, neutrons, or nucleon clusters Evolution of delivery techniques of the last 20 years “Dose sculpting hitting the target avoiding other tissues” Classic Radiotherapy Highly conformal Radiotherapy Proton vs. photontherapy tumor tumor Intensity-modulated photon radiotherapy Proton radiotherapy High therapeutic dose level Intermediate/low dose level No dose Organ at Risk Organ at Risk Photon Proton No dose “Proton beams have no exit dose” No dose
Transcript
Page 1: Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the clinic • Proton therapy delivery technology o Passive scattering o Pencil beam

6/24/17

1

Tom Depuydt, ir, PhDHead of Medical Physics

Radiation Oncology department UZ Leuven

and ParTICLe Proton Therapy Center

KU Leuven

Proton Therapy Technology in the Clinic

Scientific Meeting BVS-ABR:

“Proton therapy – From the Need to the Solution”

June 23rd 2017

From radiation physics to a clinical radiotherapy treatment modality

depth

dose

• Protons loose kinetic energy gradually when travelling through matter, through multiple collisions with atomic electrons

• The rate of energy loss or “stopping power” depends on the kinetic energy itself

• Multiple Coulomb interactions with atomic nuclei make protons scatter

• Non-elastic collisions with atomic nucleiknocks out one or more protons, neutrons, or nucleon clusters

Evolution of delivery techniques of the last 20 years

“Dose sculpting hitting the target avoiding other tissues”

Classic Radiotherapy

Highly conformal

Radiotherapy

Proton vs. photontherapy

tumor tumor

Intensity-modulated photon radiotherapy Proton radiotherapy

High therapeutic dose level

Intermediate/lowdose level

No dose

Organ at Risk

Organ at Risk

Photon Proton

No dose

“Proton beams have no exit dose”

No dose

Page 2: Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the clinic • Proton therapy delivery technology o Passive scattering o Pencil beam

6/24/17

2

?From radiation physics to a clinical radiotherapy treatment modality

depth

dose

“A whole range of technologies is necessary to fully

unleash the potential of proton therapy in the clinic”

“TECHNOLOGY is KEY”

Proton therapy technology in the clinic

• Proton therapy delivery technologyo Passive scatteringo Pencil beam scanning

• Technology to manage uncertainties in proton therapyo Image guidanceo Range verification (In-vivo)o Dual-energy CT for Stopping Power Estimationo Organ motion management/compensation

• Proton therapy facilities anno 2017o “Embedded” facilitieso Technology maturity

Layout of a “typical” PT facility

Fixed beam room

Cyclo vault

Rotating gantry room

Proton beam extracted from cyclotron

depth

dose

Bragg peak

Entrance plateau

Pencil beam

250MeV or 30 cm range

“Cyclotron produces small single high-

energy proton beam of ≈250 MeV”

Few mm width

Small “pencil beam”

Page 3: Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the clinic • Proton therapy delivery technology o Passive scattering o Pencil beam

6/24/17

3

Passive scattering energy/range modulation• Create from a Bragg peak single

energy proton beam a Spread Out Bragg Peak (SOBP) covering a

volume in depth

• SOBP is a weighted sum of Bragg

peaks

• Range modulator wheels rotate at

high frequencies and “scan” the

Bragg peak fast in depth to create a

SOBP

SOBP modulation

Passive scattering nozzle• Create from a 3 mm diameter s ingle

energy proton beam a wide beam with homogeneous intensity (s imilar to linac system for photons)

• Multiple scatterers in a cascade,

homogenous or constructed from a

combination of rings of high-Z and

low-Z materials to refocus as many

protons as possible into the field

aperture

Passive scattering nozzle

target

SOBP modulation = Cte

Aperture + compensator

• Patient-specific Apertures and range compensators are used to

shape the beam and distal edge depth of the SOBP to the target volume contours

Towards Pencil Beam Scanning …

SOBP modulation = Cte

Target

Limited extra dose

SOBP modulation

Page 4: Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the clinic • Proton therapy delivery technology o Passive scattering o Pencil beam

6/24/17

4

Scanning magnets for Pencil Beam Scanning (PBS)

F = q(v×B)

F=mv2=qvB

(if v�B)

R

BENDING

Y

X

Energy selection system

E = modified,

thus proton range is changed

Layer/Energy switching

Time=1-2 seconds

-Cyclotron produces single energy (fe. 250 MeV)-”Degrader + Bending magnet + movable slit” to select lower proton beam energy

Degrader

Dos

e

Depth

Energy switching

Scanning

target volume

Proton beam visualized in liquid scintillator solution

Courtesy PSICourtesy PSI

Pencil beam scanning over target volumeMagnetic deflection scanning

Pencil beam scanning spot maps

“Degrees of freedom”:

Spot position (X,Y)

Energy/Layer (Z)

Weight (Dose)

Page 5: Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the clinic • Proton therapy delivery technology o Passive scattering o Pencil beam

6/24/17

5

Single Field Uniform Dose (SFUD) approach

• Spot map of each treatment field generates

a uniform dose distribution in the target

volume

Intensity modulated proton therapy (IMPT) approach

• Spot map of each treatment field generates

an optimized non-uniform dose distribution

in the target volume

• Only the combination of all treatment field of

the IMPT plan generate the uniform dose yo

the target

• Better sparing of healthy tissue achieved

with IMPT then with SFUD

Clinical PT Delivery technology anno 2017

Passive scattering wide beam (PS)

PS

PBS

• Proven technology (90% PT patients

treated today)

• “Simple” wide beam approach

• Excess dose to normal tissue

• Patient specific collimators and

compensators (labor intensive)

• Significant neutron dose

Pencil beam scanning (PBS)

• More flexible (IMPT)

• No requirement of patient specific

collimators and compensators

• Interplay effects for moving targets

Neutron ambient dose Passive Scattering vs. PBS

Schneider et al. IJROBP 2002

Page 6: Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the clinic • Proton therapy delivery technology o Passive scattering o Pencil beam

6/24/17

6

Proton therapy technology in the clinic

• Proton therapy delivery technologyo Passive scatteringo Pencil beam scanning

• Technology to manage uncertainties in proton therapyo Image guidanceo Range verification (In-vivo)o Dual-energy CT for Stopping Power Estimationo Organ motion management/compensation

• Proton therapy facilities anno 2017o “Embedded” facilitieso Technology maturity

Range uncertainty issue in proton therapy

The Gare Montparnasse becam e

famous for the derailment on 22

October 1895 of the Granv ille–Par is

Express, whic h overr an the buffer

stop. The engine c areer ed acr oss

almost 30 metres (100 ft) of the

station concours e, crashed through

a 60-centimetre (2 ft) thick wal l, shot

across a terrace and sm ashed out of

the station, plummeting onto the

Place de Rennes 10 metres (33 ft)

below, where it stood on its nose.

Proton range and the train metaphor …

“Protons do stop but there is an uncertainty on where exactly”

Paganetti et al. Phys. Med. Biol. 2012 and Knopf et al. Phys. Med. Biol. 2013

Reducing uncertainties in proton therapy

“3% to 5% proton range uncertainty”

Range uncertainty issue in proton therapy

• ... due to anatomical changes

Paganetti et al. Phys. Med. Biol. 2012 and Knopf et al. Phys. Med. Biol. 2013

Page 7: Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the clinic • Proton therapy delivery technology o Passive scattering o Pencil beam

6/24/17

7

Proton therapy technology in the clinic

• Proton therapy delivery technologyo Passive scatteringo Pencil beam scanning

• Technology to manage uncertainties in proton therapyo Image guidanceo Range verification (In-vivo)o Dual-energy CT for Stopping Power Estimationo Organ motion management/compensation

• Proton therapy facilities anno 2017o “Embedded” facilitieso Technology maturity

Image guidance in PT

• Historically indications treated with PT were close to bony structures

(cranial, spine, …) which were good natural fiducials for tomor location

• Planar X-ray imaging was the standard up to only a few years ago

Base of skull chordoma

Image guidance in PT

Difference in

particle track history

Range shift

“Example: Filling nasal cavities”

Image guidance in PT: Learning from XT !?

1999: David Jaffray and first CBCT integrated in XT linac

“And the rest is history …”

2016: First CBCT-guided PT

Page 8: Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the clinic • Proton therapy delivery technology o Passive scattering o Pencil beam

6/24/17

8

Image guidance in PTIntegrated Cone-beam imaging

Dual-source on-board X-ray imaging

In-room image guidance in proton therapy

In-room CT-on-rails

CTPT

CTPT

CTPT CT

Proton therapy technology in the clinic

• Proton therapy delivery technologyo Passive scatteringo Pencil beam scanning

• Technology to manage uncertainties in proton therapyo Image guidanceo Range verification (In-vivo)o Dual-energy CT for Stopping Power Estimationo Organ motion management/compensation

• Proton therapy facilities anno 2017o “Embedded” facilitieso Technology maturity

Range verification in PT: Prompt gamma imaging

• Resulting from inelastic interactions of incident protons and target nuclei

• The nucleus is excited to a higher energy state and emits

a single photon (PG) as it returns to the ground state

• the isotropic PG rays can be detected instantaneously(within a few nanoseconds) following the nuclear

interactions

• Wide energy spectrum, between 0 and 7 MeV

• reasonably high production rate/signal for a typical

therapeutic dose of 2 Gy min−1

• PG are produced along the proton tracks, the path of a

pencil beam within the patient could be imaged as a line source by an adequate gamma camera.

• Real-time online verification method

Moteabbed et al. Phys Med Biol 2011

Slit-design gamma camera (IBA prototype)

Smeets et al. Phys Med Biol 2012

Page 9: Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the clinic • Proton therapy delivery technology o Passive scattering o Pencil beam

6/24/17

9

Range verification in PT: Prompt gamma imaging

Smeets et al. Phys Med Biol 2012

Range verification in PT: Prompt gamma imaging

Slit cameraNozzle

Deviatio

n p

en

cil b

eam

ran

ge

Patient

Range verification in PT: In-vivo PET imaging

• Inelastic interaction of the proton beam with atomic nuclei create unstable isotopes

• Excited atomic nuclei undergo β+- decay and emit characteristic positrons

• 11C (T1/2 = 20.39 min), 15O (T1/2 = 2.03 min), 13N (T1/2 = 9.97 min), 30P (T1/2 = 2.50

min) and 38K (T1/2 = 7.63 min)

• Annihilation of positrons create a 511 keVgamma pair detectable by the PET scanner coincidence measurement

Moteabbed et al. Phys Med Biol 2011

Range verification in PT: In-vivo PET imaging

Page 10: Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the clinic • Proton therapy delivery technology o Passive scattering o Pencil beam

6/24/17

10

Range verification in PT: In-vivo PET imaging• No direct correlation with dose distribution

• Agreement with calculations with accuracy of 1-2 mm

• Signal related to local elemental composition of tissues (C,O, …) and activation timing in delivery process (PBS)

• Delay between PT delivery and offline PET read-out (typical 20 min),

resulting in:

o Loss of signal (11C T1/2=20 min, 15OT1/2=2 min)

o Physiological processes (blood perfusion, metabolism) cause biological wash-out (location dependent)

• other patient position PET vs PT, coregistration issues

Moteabbed et al. Phys Med Biol 2011 Parodi et al. Phys Med Biol 2002, 2005, 2007a/b

Sim. PET signal PET signalDose

Range verification in PT: In-vivo PET imaging

Parodi et al. Phys Med Biol 2002, 2005, 2007a/b

Transfer to diagnostic PETIn-room PET

Online PET has less delay (2 min), higher signal, less wash-out, no coregitration issues

Read-out delay (20 min), low signal (mainly 11C), wash-out, coregitration issues with treatment position PT

Proton therapy technology in the clinic

• Proton therapy delivery technologyo Passive scatteringo Pencil beam scanning

• Technology to manage uncertainties in proton therapyo Image guidanceo Range verification (In-vivo)o Dual-energy CT for Stopping Power Estimationo Organ motion management/compensation

• Proton therapy facilities anno 2017o “Embedded” facilitieso Technology maturity

Dual Energy CT imaging for Stopping Power Ratio estimation

• An estimation of Proton Stopping Power

Ratio’s (SPR) based on Single Energy CT

(SECT) has the issue that

materials/tissues with the same CT-number could have a different elementalcomposition, and SPR.

• Conversion of SECT into stopping powerresults in ~3-4% range uncertainty

• Dual energy computed tomography(DECT) can provide simultaneous

estimation of relative electron density ρe

and effective atomic number Zeff.

• Using the Bethe-Bloch formula SPR’s can

be estimated of different tissues based on a

DECT of the patient

Schneider et al. Phys Med Biol 1996

Page 11: Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the clinic • Proton therapy delivery technology o Passive scattering o Pencil beam

6/24/17

11

Estimation of protonDual Energy CT imaging for Stopping Power Ratio estimation Dual Energy CT imaging for Stopping Power Ratio estimation

Dual-source CT (Siemens) Twinbeam (Siemens)

Au-filter Sn-filter

DECT Technology Overview

Dual Energy CT imaging for Stopping Power Ratio estimation Proton therapy technology in the clinic

• Proton therapy delivery technologyo Passive scatteringo Pencil beam scanning

• Technology to manage uncertainties in proton therapyo Image guidanceo Range verificationo Dual-energy CT for Stopping Power Estimationo Organ motion management/compensation

• Proton therapy facilities anno 2017o “Embedded” facilitieso Technology maturity

Page 12: Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the clinic • Proton therapy delivery technology o Passive scattering o Pencil beam

6/24/17

12

Impact of organ motion on PBS dose delivery

0 1 2 3 4 5 6 7 8 9 100

0.5

1

1.5

2

2.5

Interplay effect between PBS scanned dose delivery and organ motion

Generating high dose region using

multiple pencil beams (spots)

“static” dose

0 1 2 3 4 5 6 7 8 9 100

0.5

1

1.5

2

2.5

Organ motion can change the position of the spots

relative to each other, resulting in hot/cold spots

Dose to a moving target

0 1 2 3 4 5 6 7 8 9 100

0.5

1

1.5

2

2.5

3

Rescanning N-times reduces the interplay effects

and approximately re-established the “static” dose

“static” dose

Dose to moving target

with N-times rescanning

Organ motion management/compensation

Proton therapy technology in the clinic

• Proton therapy delivery technologyo Passive scatteringo Pencil beam scanning

• Technology to manage uncertainties in proton therapyo Image guidanceo Range verification (In-vivo)o Dual-energy CT for Stopping Power Estimationo Organ motion management/compensation

• Proton therapy facilities anno 2017o “Embedded” facilitieso Technology maturity

History of Proton Therapy (PT) facilities

A by-product

“PT facilities evolves from being …”

EmbeddedModality

NUCLEAR

PHYSICS

RESEARCH

FACILITY

PT

Dedicated stand-alonefacility

PT

HOSPITAL

PT

PHYSICS/BIOLOGYRESEAR

CHFACILITY

Page 13: Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the clinic • Proton therapy delivery technology o Passive scattering o Pencil beam

6/24/17

13

PT Facility size

60x100 meter

“The metaphors in PT …” “Size measure of PT centers … sport field?”

Range uncertainty

“Compact systems as enabling technology for embedding PT… ?”

15x28 meter

11x24 meter

PT Facility size

Impression of finished ParTICLe facility

UZ Leuven campus Gasthuisberg

PT EMBEDDED IN UZ LEUVEN

GASTHUISBERG CAMPUS

R

T

IBA S2C2 superconducting synchrocyclotron IBA Proteus ONE compact gantry beam-line

Scanning magnets

Energy selection

“Compact” PT systems

Page 14: Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the clinic • Proton therapy delivery technology o Passive scattering o Pencil beam

6/24/17

14

ParTICLe Proton Therapy center in Leuven (Embedded)

Existing Radiation Oncology dept., UZ Leuven

C

Lab Access

PT AClinical

Treatment

room 1

PT BResearch

room (future

clinical 2)

66

m

23

m

Linac 5 XT Linac 4 XT Linac 3 XT Linac 2 XT Linac 1 XT

CT 1

CT 2

PDR BT

HDR BT

PT A

PT A: CLINICAL TREATMENT ROOM

Specifications:-IBA Proteus ONE system

-Compact gantry with 220° rotation

-Patient positioning robot

-1 kHz Pulsed proton beam

-230 MeV maximum energy (32 cm WET)

-70 MeV minimum energy (degraded)

-Field size 20x24 cm (scanning range)

-Spot size in air (100MeV): !<6 mm

-Scanning SAD >3m (X) and >7m (Y)

10-15 "s10 pC

Charge

Time

XT PT

Volumetric image guidance (CBCT only recently introduced in PT)

Adaptive Radiotherapy (Probably more needed in PT)

(revival in XT?)

RT of moving tumors (Issues to solve in PBS, triggers development

of motion management strategies in PBS-only

environments)

(Could/will finds its way to XT) PTV-less robust planning strategies“Classic margin recipies invalid?!”

IMRT (IMPT find its way to mainstream PT)

Concluding remarks …

“Embedded PT facilities, PT becoming main stream and Technological cross-talk between XT and PT”

• AAPM Report 16 (1986), Protocol for heavy charged-particle therapy beam dosimetry, no PBS

• ICRU Report 59 (1998) , Clinical Proton dosimetry, no PBS

• IAEA TRS-398 (2000), The current Code of Practice for proton dosimetry no PBS

• ICRU Report 78 (2007), coverage PBS limited

• IAEA: Update of TRS-398 (<2020?)

• AAPM TG-185: Commissioning of Proton Therapy Systems

• AAPM TG-224: Proton Machine QA

• NCS subcommittee on proton dosimetry

• EPTN ("ESTRO initiative")

• IPEM

“The current activity of different guideline working groups shows that PBS is getting to maturity, but it is not there yet. It also shows that existing guidelines do not meet the current needs.”

Publishes guidelines Guidelines in preparation

International guidelines for PBS PT ?!

Concluding remarks …

Page 15: Proton Therapy Technology in the Clinic by T Depuydt · 6/24/17 6 Proton therapy technology in the clinic • Proton therapy delivery technology o Passive scattering o Pencil beam

6/24/17

15

Concluding remarks …

“Sticking to the train metaphor …”

… is like jumping a moving train

Range uncertainty

Getting trained on PBS PT today ...

Assimilate proton therapy technology/methodology today

ParTICLe

“Particle Therapy Interuniversitary Center Leuven”

Some dates:-End of construction works: Q1 2018

-Delivery PT system: Q1 2018

-Acceptance Testing: Q1 2019

-Clinical commissioning: Q2 2019

-First patient treatment: Q3 2019


Recommended